Health Care: Drugs

Arrowhead Pharmaceuticals Inc (ARWR: NASDAQ)

$1.55 n/a | n/a%
06/23/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.55
52 Week High 8.22
52 Week Low 1.20
Avg. Daily Vol. (Mil) 0.81
Beta (3 year) 1.12
Share Related Items
Mkt Cap (Mil) 115.90
Shares Out (Mil) 74.77
Float (Mil) 73.62
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.80
Current Ratio 2.90
LT Debt/ Equity 0.03
Total Debt / Equity 0.03
Valuation Ratios
Price Earnings n.a.
Price/Sales 25.87
Price/Book 1.19
Price/Cash Flow -1.60
Per Share Data
Earnings -1.18
Sales 0.06
Book Value 1.31
Cash Flow -0.95
Business Summary
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
General Information
225 South Lake Avenue
Suite 1050
Pasedena, CA 91101
Industry : Drugs
Sector: Health Care
Employees: 113
CEO: Dr. Christopher Anzalone,PhD
Short Interest
Current Month (Mil) 12.72
Previous Month (Mil) 11.41
Short Interest Ratio (Days) 16.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -51.70
Return on Investments -74.40
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARWR

Latest ARWR Headlines from TheStreet

More Financial News for ARWR

Press Releases for ARWR

See All Press Releases

Partner Headlines for ARWR

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter